Table 2.
Potency value and content of active compounds.
| NO. | Compound | Target | EC50/IC50 (μM) | Agonist/antagonist | Content μg/mg |
|---|---|---|---|---|---|
| 1 | licochalcone B | GPR35 | 25.12 | agonist | 0.000822 |
| 2 | tectorigenin | GPR35 | >200 | agonist | 0.004408 |
| 3 | taxifolin | GPR35 | >200 | agonist | 0.000486 |
| 4 | isochlorogenic acid C | GPR35 | 114.30 | agonist | 0.183710 |
| 5 | isoliquiritigenin | GPR35 | >200 | agonist | 0.000073 |
| 6 | baicalin | GPR35 | >200 | agonist | 2.571457 |
| 7 | scutellarin | GPR35 | 86.26 | agonist | 0.171974 |
| 8 | caffeic acid | GPR35 | 290 a | agonist | 0.0344684 |
| 9 | gallic acid | GPR35 | 1.16 a | agonist | 0.008892 |
| 10 | baicalein | GPR35 | 10.3 a | agonist | 0.003157 |
| 11 | luteolin | GPR35 | 7.24 a | agonist | 0.001091 |
| 12 | quercetin | GPR35 | 8.02 a | agonist | 0.003465 |
| 13 | kynurenic acid | GPR35 | 152 a | agonist | 0.008850 |
| 14 | atractyline | CB2 | 65.23 | agonist | undetected |
| 15 | shogaol | H1 | >200 | antagonist | undetected |
| 1 | licochalcone B | B2 | 139.70 | antagonist | 0.000822 |
| 16 | alisol A | B2 | >200 | antagonist | 0.001993 |
| 5 | isoliquiritigenin | B2 | >200 | antagonist | 0.000073 |
| 17 | ephedrine | β2-adrenoceptor | 0.49 | agonist | 1.391095 |
| 18 | pseudoephedrine | β2-adrenoceptor | 9.00 | agonist | 0.823086 |
| 19 | synephrine | β2-adrenoceptor | 0.25 | agonist | 0.162534 |
| 2 | tectorigenin | M3 | >200 | antagonist | 0.0044075 |
| 20 | aristofone | M3 | >200 | antagonist | undetected |
The superscript letter a in column four indicates that the EC50/IC50 value measured using the DMR technique comes from literatures.